Xencor Inc Sustainability Reports
Xencor, Inc. is a clinical-stage biopharmaceutical company that discovers and develops engineered monoclonal antibodies and biotherapeutic drug candidates. The company utilizes its proprietary XmAb technology platform to optimize antibodies for treating patients with cancer and autoimmune diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300V5IF65437JKG30
FIGI: BBG0026ZG4X9
7 reports from 2014 to 2023